Trademark: 79272513
Word
GK
Status Date
Tuesday, July 20, 2021
Registration Number
6422155
Registration Date
Tuesday, July 20, 2021
Filing Date
Wednesday, September 11, 2019
Published for Opposition
Tuesday, May 4, 2021
5 Pharmaceutical preparations for human use to minimize heterogeneity caused by endogenous enzymes in the course of cell culture for preventing or treating infectious and parasitic diseases, cancer, blood and blood-forming organs diseases and disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, certain conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities, namely, pharmaceutical antibodies or its fragments or its derivatives; cells and genes that produce antibodies, fragments of antibodies or derivatives of antibodies for medical use
45 Granting of licenses to others for the use of industrial property rights and copyright
42 Pharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals
The mark consists of the stylized Greek letter "Delta" and the stylized Latin letters "GK".
Color is not claimed as a feature of the mark.
The transliteration of the non-Latin characters in the mark is: "delta".
Jan 28, 2023
New Representative At Ib Received
Jan 10, 2022
Final Decision Transaction Processed By Ib
Dec 1, 2021
Generic Madrid Transaction Sent To Ib
Dec 1, 2021
Generic Madrid Transaction Created
Oct 20, 2021
Final Disposition Notice Created, To Be Sent To Ib
Jul 20, 2021
Registered-Principal Register
May 10, 2021
Notification Of Possible Opposition - Processed By Ib
May 4, 2021
Official Gazette Publication Confirmation E-Mailed
May 4, 2021
Published For Opposition
May 2, 2021
Notification Processed By Ib
Apr 21, 2021
Notification Of Possible Opposition Sent To Ib
Apr 21, 2021
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 14, 2021
Notification Of Possible Opposition Sent To Ib
Apr 14, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 14, 2021
Notification Of Notice Of Publication E-Mailed
Mar 29, 2021
Approved For Pub - Principal Register
Mar 29, 2021
Examiner's Amendment Entered
Mar 29, 2021
Notification Of Examiners Amendment E-Mailed
Mar 29, 2021
Examiners Amendment E-Mailed
Mar 29, 2021
Examiners Amendment -Written
Feb 10, 2021
Teas Request For Reconsideration Received
Feb 10, 2021
Ex Parte Appeal-Instituted
Feb 10, 2021
Jurisdiction Restored To Examining Attorney
Feb 10, 2021
Exparte Appeal Received At Ttab
Aug 12, 2020
Notification Of Final Refusal Emailed
Aug 12, 2020
Final Refusal E-Mailed
Aug 12, 2020
Final Refusal Written
Jul 23, 2020
Teas/Email Correspondence Entered
Jul 22, 2020
Correspondence Received In Law Office
Jul 22, 2020
Teas Response To Office Action Received
Jun 19, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 19, 2020
Teas Change Of Correspondence Received
Jun 19, 2020
Teas Change Of Domestic Representatives Address
Jun 19, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 19, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 19, 2020
Teas Change Of Owner Address Received
Feb 15, 2020
Refusal Processed By Ib
Jan 24, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Jan 24, 2020
Refusal Processed By Mpu
Dec 13, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Dec 12, 2019
Non-Final Action Written
Dec 11, 2019
Assigned To Examiner
Nov 29, 2019
Application Filing Receipt Mailed
Nov 25, 2019
New Application Office Supplied Data Entered
Nov 21, 2019
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
